First Tracks Biotherapeutics (TRAX) Stock Fundamentals

First Tracks Biotherapeutics Inc is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Daniel R. Faga.

Earnings

Aug 7, 2026 (Today)

Revenue estimate$75.0M

EPS estimate-$0.80

Operating income-$52.8M-3.0%

Net income-$50.5M-7.0%

Cash & equivalents$248.5M—

Total debt$14.1M—

Total equity$257.5M-28.0%

Total assets$290.6M—

Operating cash flow-$32.6M+27.7%

CapEx$17.0K-51.4%

Free cash flow-$32.6M+27.7%

CEODaniel R. Faga